% | $
Quotes you view appear here for quick access.

Cempra, Inc. Message Board

prpitches 2 posts  |  Last Activity: Feb 6, 2012 10:33 AM Member since: Jan 12, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • (Chapel Hill, N.C.) Cempra (CEMP), a Chapel Hill pharmaceutical firm launched in 2006, went public on the Nasdaq late last week raising $50.4 million in an 8.4 million share offering at $6 per share, well below its target range of $11 to $13. The company, with two oral antibiotics that have completed mid-stage clinical trials, had originally hoped to raise about $72 million by selling 6 million shares.

    Shares began trading at $6.18 and hit a high of $6.58 before closing at $6.06. Cempra is the second drug developer to go public nationwide in 2012. The first therapeutic IPO, Massachusetts-based Verastem, a pre-clinical drug developer, generated much more enthusiasm in its debut one week before Cempra’s offering. The company was trading up 10 percent one week after making its debut.


  • The price to attend the 2010 2010 Southeast Venture Conference (SEVC) is $390 through January 22; after that date, the price goes up to $490 for attendees who register between January 23 and February 23, and $590 at the conference. All previous Southeast Venture Conferences have sold out. Attendees are encouraged to register early to ensure space availability.

    Read more here:

35.80+1.40(+4.07%)Aug 28 4:00 PMEDT